LSCP Insider Trading
LSCP | Market Equity
Comprehensive Trading Performance Summary
The investment history of corporate insiders at LSCP provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2006-07-28 00:28 | 2006-07-25 | AMERICAN MEDICAL SYSTEMS HOLDINGS INC | 10% owner | BUY | $31.00 | 2,122,826 | $65,807,606 | 22,558,565 | +10.4% |
| 2006-06-19 23:54 | 2006-06-15 | PEARSON ROBERT C | Director | SELL | $30.68 | 600,000 | $18,405,780 | 0 | -100.0% |
| 2006-06-14 22:14 | 2005-11-07 | BAUMGARDT JAMES | Director | BUY | $21.23 | 1,000 | $21,234 | 2,600 | +62.5% |
| 2006-02-07 21:12 | 2006-02-06 | PRESSLEY ROBERT | Director | OPT+S | $25.15 | 3,000 | $75,443 | 21,016 | 0.0% |
| 2006-02-07 21:41 | 2006-01-05 | PRESSLEY ROBERT | Director | OPT+S | $26.81 | 6,000 | $160,860 | 21,016 | 0.0% |
| 2006-01-06 20:34 | 2006-01-05 | PRESSLEY ROBERT | Director | OPT+S | $26.81 | 3,000 | $80,430 | 21,016 | 0.0% |
| 2006-01-07 02:22 | 2006-01-05 | PRESSLEY ROBERT | Director | OPT+S | $26.81 | 9,000 | $241,290 | 21,016 | 0.0% |
| 2005-11-10 04:29 | 2005-11-09 | FINNEY ELISHA W | Director | BUY | $22.20 | 1,000 | $22,200 | 2,000 | +100.0% |
| 2005-10-07 00:18 | 2005-10-05 | PRESSLEY ROBERT | Director | OPT+S | $28.72 | 3,000 | $86,155 | 21,016 | 0.0% |
| 2005-09-07 19:26 | 2005-09-06 | PRESSLEY ROBERT | Director | OPT+S | $29.20 | 3,000 | $87,585 | 21,016 | 0.0% |
| 2005-08-17 22:38 | 2005-08-17 | FINNEY ELISHA W | Director | BUY | $29.70 | 1,000 | $29,700 | 1,000 | +100.0% |
| 2005-08-09 23:40 | 2005-08-05 | PRESSLEY ROBERT | Director | SELL | $13.54 | 3,000 | $40,630 | 21,016 | -12.5% |
| 2005-05-05 20:43 | 2005-05-04 | MATHEWS ROBERT | Officer - Group VP Ops & Prod. Dev. | OPT+S | $31.25 | 10,250 | $320,302 | 0 | 0.0% |
| 2004-11-18 00:20 | 2004-11-16 | MANN ROBERT | Officer - VP N American Sales & Mrkting | SELL | $31.38 | 750 | $23,534 | 113 | -86.9% |
| 2004-11-09 22:00 | 2004-11-08 | FRAZIER VAN | Officer - VP Reg Affairs & Quality Assur | OPT+S | $27.90 | 80,171 | $2,236,771 | 3,763 | 0.0% |
| 2004-11-09 21:11 | 2004-11-08 | LALUMANDIERE DENNIS | Officer - VP, Finance and CFO | OPT+S | $28.35 | 51,960 | $1,472,858 | 50,472 | 0.0% |
| 2004-11-02 22:26 | 2004-11-01 | MANN ROBERT | Officer - VP N America Sales & Marketing | OPT+S | $25.86 | 18,541 | $479,470 | 863 | 0.0% |
| 2004-11-02 22:03 | 2004-11-01 | ARNOLD KEN | Officer - Vice President R&D | OPT+S | $26.11 | 60,000 | $1,566,774 | 8,276 | 0.0% |
| 2004-11-02 23:23 | 2004-11-01 | MATHEWS ROBERT | Officer - Executive VP | OPT+S | $26.06 | 104,812 | $2,731,526 | 5,000 | 0.0% |
| 2004-06-15 19:00 | 2004-06-14 | PERKINS RODNEY MD | Director | OPT+S | $29.57 | 105,000 | $3,105,165 | 0 | 0.0% |
| 2004-06-11 01:04 | 2004-06-09 | REUTER ERIC | Officer - President & CEO | OPT+S | $31.42 | 60,000 | $1,885,140 | 180,685 | 0.0% |
| 2004-06-09 22:41 | 2004-06-08 | REUTER ERIC | Officer - President and CEO | OPT+S | $31.05 | 134,997 | $4,192,264 | 160,685 | 0.0% |
| 2004-05-26 21:09 | 2004-05-25 | BAUMGARDT JAMES | Director | SELL | $27.93 | 6,400 | $178,740 | 1,600 | -80.0% |
| 2004-05-26 20:58 | 2004-05-18 | BAUMGARDT JAMES | Director | SELL | $29.62 | 6,500 | $192,548 | 14,500 | -31.0% |
| 2004-05-21 18:06 | 2004-05-20 | BAUMGARDT JAMES | Director | SELL | $29.50 | 1,000 | $29,500 | 8,500 | -10.5% |
| 2004-05-20 20:02 | 2004-05-19 | BAUMGARDT JAMES | Director | SELL | $30.35 | 5,500 | $166,925 | 9,500 | -36.7% |
| 2004-05-19 01:05 | 2004-05-18 | BAUMGARDT JAMES | Director | SELL | $29.60 | 6,000 | $177,605 | 15,000 | -28.6% |
| 2004-05-13 22:30 | 2002-10-30 | BAUMGARDT JAMES | Director | BUY | $3.90 | 1,000 | $3,900 | 1,000 | +100.0% |
| 2004-05-07 19:30 | 2004-05-06 | FRAZIER VAN | Officer - VP Reg Affairs & Quality Assur | OPT+S | $31.96 | 1,000 | $31,955 | 31,488 | 0.0% |
| 2004-04-30 20:12 | 2004-04-29 | ARNOLD KEN | Officer - Vice President of R&D | OPT+S | $31.64 | 16,000 | $506,205 | 8,156 | 0.0% |
| 2004-04-29 01:19 | 2004-04-27 | MANN ROBERT | Officer - VP N American Sales Marketing | OPT+S | $31.74 | 7,500 | $238,026 | 681 | 0.0% |
| 2004-04-29 02:07 | 2004-04-27 | FRAZIER VAN | Officer - VP Reg Affairs & Quality Assur | OPT+S | $31.74 | 50,689 | $1,608,707 | 15,296 | 0.0% |
| 2004-04-29 00:52 | 2004-04-27 | MATHEWS ROBERT | Officer - Executive Vice President | OPT+S | $31.74 | 60,450 | $1,918,490 | 51,000 | 0.0% |
| 2004-04-28 22:07 | 2004-04-27 | LALUMANDIERE DENNIS | Officer - VP, Finance and CFO | OPT+S | $31.74 | 50,000 | $1,586,840 | 50,315 | 0.0% |
| 2004-03-17 20:20 | 2004-03-16 | MATHEWS ROBERT | Officer - Executive Vice President | OPT+S | $20.98 | 63,000 | $1,321,740 | 51,000 | 0.0% |
| 2004-03-13 02:46 | 2004-03-12 | FRAZIER VAN | Officer - VP Reg Affairs & Quality Assur | OPT+S | $22.84 | 1,800 | $41,112 | 41,963 | 0.0% |
| 2004-02-28 03:32 | 2004-02-27 | PRESSLEY ROBERT | Director | OPT+S | $23.03 | 20,000 | $460,600 | 21,016 | 0.0% |
| 2004-02-28 02:58 | 2004-02-27 | REUTER ERIC | Officer - President & CEO | OPT+S | $23.63 | 37,877 | $895,071 | 160,685 | 0.0% |
| 2004-02-27 02:51 | 2004-02-25 | REUTER ERIC | Officer - President and CEO | OPT+S | $23.71 | 132,500 | $3,141,469 | 131,062 | 0.0% |
| 2004-02-19 20:03 | 2004-02-19 | PEARSON ROBERT C | Director | SELL | $21.50 | 1,300,000 | $27,950,000 | 431,500 | -75.1% |
| 2003-12-09 20:29 | 2003-12-08 | FRAZIER VAN | Officer - VP Reg.Affairs & Quality Assur | OPT+S | $16.51 | 10,000 | $165,100 | 13,763 | 0.0% |
| 2003-12-05 21:42 | 2003-12-04 | PERKINS RODNEY MD | Director | SELL | $16.53 | 16,667 | $275,506 | 0 | -100.0% |
| 2003-12-04 20:46 | 2003-12-03 | REUTER ERIC | Officer - President and CEO | OPT+S | $17.09 | 8,000 | $136,720 | 89,062 | 0.0% |
| 2003-11-11 01:40 | 2003-11-07 | LALUMANDIERE DENNIS | Officer - VP, Finance and CFO | OPT+S | $13.08 | 15,000 | $196,200 | 41,565 | 0.0% |
| 2003-11-07 01:50 | 2003-11-06 | MATHEWS ROBERT | Officer - Executive Vice President | SELL | $13.01 | 3,000 | $39,042 | 51,000 | -5.6% |
| 2003-09-16 19:26 | 2003-09-15 | PERKINS RODNEY MD | Director | SELL | $11.08 | 25,399 | $281,373 | 16,667 | -60.4% |
| 2003-08-16 00:52 | 2003-08-15 | MANN ROBERT | Officer - VP, N. American Sales & Mktg. | OPT+S | $10.37 | 9,375 | $97,219 | 519 | 0.0% |
| 2003-08-13 19:10 | 2003-08-12 | LALUMANDIERE DENNIS | Officer - VP, Finance CFO | OPT+S | $9.97 | 4,900 | $48,853 | 41,565 | 0.0% |
| 2003-08-05 19:57 | 2003-08-04 | LALUMANDIERE DENNIS | Officer - VP,Finance CFO | OPT+S | $10.00 | 7,000 | $70,000 | 41,565 | 0.0% |
| 2003-08-04 21:16 | 2003-08-01 | MANN ROBERT | Officer - VP, N. American Sales & Mktg. | SELL | $10.25 | 500 | $5,125 | 519 | -49.1% |
How to Interpret $LSCP Trades
Not every insider transaction in LSCP is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $LSCP shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for LSCP
Insider activity data for LSCP is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $LSCP, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.